 | • レポートコード：MRC2-11QY10567 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は治療用ワクチンのグローバル市場について調査・分析したレポートです。種類別（ペプチド治療ワクチン、細胞治療ワクチン、核酸治療ワクチン）市場規模、用途別（腫瘍療法、B型肝炎、結核、単純ヘルペスウイルス、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別治療用ワクチンの競争状況、市場シェア ・世界の治療用ワクチン市場：種類別市場規模 2015年-2020年（ペプチド治療ワクチン、細胞治療ワクチン、核酸治療ワクチン） ・世界の治療用ワクチン市場：種類別市場規模予測 2021年-2026年（ペプチド治療ワクチン、細胞治療ワクチン、核酸治療ワクチン） ・世界の治療用ワクチン市場：用途別市場規模 2015年-2020年（腫瘍療法、B型肝炎、結核、単純ヘルペスウイルス、その他） ・世界の治療用ワクチン市場：用途別市場規模予測 2021年-2026年（腫瘍療法、B型肝炎、結核、単純ヘルペスウイルス、その他） ・北米の治療用ワクチン市場分析：米国、カナダ ・ヨーロッパの治療用ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの治療用ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の治療用ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの治療用ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Northeast Biotherapeutics、Agenus、Vaccinogen Inc、CIMAB S.A、Dendreon、Corixa、AVAX Technologies ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Therapeutic Vaccines Market
The global Therapeutic Vaccines market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Therapeutic Vaccines Scope and Market Size
Therapeutic Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Therapeutic Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Therapeutic Vaccines market is segmented into
Peptide Therapeutic Vaccine
Cell Therapeutic Vaccine
Nucleic Acid Therapeutic Vaccine
Segment by Application, the Therapeutic Vaccines market is segmented into
Oncotherapy
Hepatitis B
Tuberculosis
Herpes Simplex Virus
Others
Regional and Country-level Analysis
The Therapeutic Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Therapeutic Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Therapeutic Vaccines Market Share Analysis
Therapeutic Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Therapeutic Vaccines business, the date to enter into the Therapeutic Vaccines market, Therapeutic Vaccines product introduction, recent developments, etc.
The major vendors covered:
Northeast Biotherapeutics
Agenus
Vaccinogen Inc
CIMAB S.A
Dendreon
Corixa
AVAX Technologies
…
1 Study Coverage
1.1 Therapeutic Vaccines Product Introduction
1.2 Market Segments
1.3 Key Therapeutic Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Therapeutic Vaccines Market Size Growth Rate by Type
1.4.2 Peptide Therapeutic Vaccine
1.4.3 Cell Therapeutic Vaccine
1.4.4 Nucleic Acid Therapeutic Vaccine
1.5 Market by Application
1.5.1 Global Therapeutic Vaccines Market Size Growth Rate by Application
1.5.2 Oncotherapy
1.5.3 Hepatitis B
1.5.4 Tuberculosis
1.5.5 Herpes Simplex Virus
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Therapeutic Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Therapeutic Vaccines Revenue 2015-2026
2.1.2 Global Therapeutic Vaccines Sales 2015-2026
2.2 Global Therapeutic Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Therapeutic Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Therapeutic Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Therapeutic Vaccines Competitor Landscape by Players
3.1 Therapeutic Vaccines Sales by Manufacturers
3.1.1 Therapeutic Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Therapeutic Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Therapeutic Vaccines Revenue by Manufacturers
3.2.1 Therapeutic Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Therapeutic Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Therapeutic Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Therapeutic Vaccines Revenue in 2019
3.2.5 Global Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Therapeutic Vaccines Price by Manufacturers
3.4 Therapeutic Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Therapeutic Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Therapeutic Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Therapeutic Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Therapeutic Vaccines Market Size by Type (2015-2020)
4.1.1 Global Therapeutic Vaccines Sales by Type (2015-2020)
4.1.2 Global Therapeutic Vaccines Revenue by Type (2015-2020)
4.1.3 Therapeutic Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Therapeutic Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Therapeutic Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Therapeutic Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Therapeutic Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Therapeutic Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Therapeutic Vaccines Market Size by Application (2015-2020)
5.1.1 Global Therapeutic Vaccines Sales by Application (2015-2020)
5.1.2 Global Therapeutic Vaccines Revenue by Application (2015-2020)
5.1.3 Therapeutic Vaccines Price by Application (2015-2020)
5.2 Therapeutic Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Therapeutic Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Therapeutic Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Therapeutic Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Therapeutic Vaccines by Country
6.1.1 North America Therapeutic Vaccines Sales by Country
6.1.2 North America Therapeutic Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Therapeutic Vaccines Market Facts & Figures by Type
6.3 North America Therapeutic Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Therapeutic Vaccines by Country
7.1.1 Europe Therapeutic Vaccines Sales by Country
7.1.2 Europe Therapeutic Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Therapeutic Vaccines Market Facts & Figures by Type
7.3 Europe Therapeutic Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Therapeutic Vaccines by Region
8.1.1 Asia Pacific Therapeutic Vaccines Sales by Region
8.1.2 Asia Pacific Therapeutic Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Therapeutic Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Therapeutic Vaccines by Country
9.1.1 Latin America Therapeutic Vaccines Sales by Country
9.1.2 Latin America Therapeutic Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Therapeutic Vaccines Market Facts & Figures by Type
9.3 Central & South America Therapeutic Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Therapeutic Vaccines by Country
10.1.1 Middle East and Africa Therapeutic Vaccines Sales by Country
10.1.2 Middle East and Africa Therapeutic Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Therapeutic Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Northeast Biotherapeutics
11.1.1 Northeast Biotherapeutics Corporation Information
11.1.2 Northeast Biotherapeutics Description and Business Overview
11.1.3 Northeast Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
11.1.5 Northeast Biotherapeutics Related Developments
11.2 Agenus
11.2.1 Agenus Corporation Information
11.2.2 Agenus Description and Business Overview
11.2.3 Agenus Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Agenus Therapeutic Vaccines Products Offered
11.2.5 Agenus Related Developments
11.3 Vaccinogen Inc
11.3.1 Vaccinogen Inc Corporation Information
11.3.2 Vaccinogen Inc Description and Business Overview
11.3.3 Vaccinogen Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Vaccinogen Inc Therapeutic Vaccines Products Offered
11.3.5 Vaccinogen Inc Related Developments
11.4 CIMAB S.A
11.4.1 CIMAB S.A Corporation Information
11.4.2 CIMAB S.A Description and Business Overview
11.4.3 CIMAB S.A Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CIMAB S.A Therapeutic Vaccines Products Offered
11.4.5 CIMAB S.A Related Developments
11.5 Dendreon
11.5.1 Dendreon Corporation Information
11.5.2 Dendreon Description and Business Overview
11.5.3 Dendreon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dendreon Therapeutic Vaccines Products Offered
11.5.5 Dendreon Related Developments
11.6 Corixa
11.6.1 Corixa Corporation Information
11.6.2 Corixa Description and Business Overview
11.6.3 Corixa Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Corixa Therapeutic Vaccines Products Offered
11.6.5 Corixa Related Developments
11.7 AVAX Technologies
11.7.1 AVAX Technologies Corporation Information
11.7.2 AVAX Technologies Description and Business Overview
11.7.3 AVAX Technologies Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AVAX Technologies Therapeutic Vaccines Products Offered
11.7.5 AVAX Technologies Related Developments
11.1 Northeast Biotherapeutics
11.1.1 Northeast Biotherapeutics Corporation Information
11.1.2 Northeast Biotherapeutics Description and Business Overview
11.1.3 Northeast Biotherapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Northeast Biotherapeutics Therapeutic Vaccines Products Offered
11.1.5 Northeast Biotherapeutics Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Therapeutic Vaccines Market Estimates and Projections by Region
12.1.1 Global Therapeutic Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Therapeutic Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Therapeutic Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Therapeutic Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Therapeutic Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Therapeutic Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Therapeutic Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Therapeutic Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Therapeutic Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Therapeutic Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Therapeutic Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Therapeutic Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Therapeutic Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Therapeutic Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Therapeutic Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Therapeutic Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Therapeutic Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Therapeutic Vaccines Market Segments
Table 2. Ranking of Global Top Therapeutic Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Therapeutic Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Peptide Therapeutic Vaccine
Table 5. Major Manufacturers of Cell Therapeutic Vaccine
Table 6. Major Manufacturers of Nucleic Acid Therapeutic Vaccine
Table 7. Global Therapeutic Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Therapeutic Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Therapeutic Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global Therapeutic Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Therapeutic Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Therapeutic Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Therapeutic Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global Therapeutic Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Therapeutic Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Therapeutic Vaccines as of 2019)
Table 16. Therapeutic Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Therapeutic Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Therapeutic Vaccines Price (2015-2020) (USD/Unit)
Table 19. Therapeutic Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Therapeutic Vaccines Product Type
Table 21. Date of International Manufacturers Enter into Therapeutic Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 24. Global Therapeutic Vaccines Sales Share by Type (2015-2020)
Table 25. Global Therapeutic Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Therapeutic Vaccines Revenue Share by Type (2015-2020)
Table 27. Therapeutic Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 29. Global Therapeutic Vaccines Sales Share by Application (2015-2020)
Table 30. North America Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 31. North America Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 35. North America Therapeutic Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 37. North America Therapeutic Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 39. Europe Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 43. Europe Therapeutic Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 45. Europe Therapeutic Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Therapeutic Vaccines Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Therapeutic Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Therapeutic Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Therapeutic Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Therapeutic Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Therapeutic Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 55. Latin America Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 59. Latin America Therapeutic Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 61. Latin America Therapeutic Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Therapeutic Vaccines Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Therapeutic Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Therapeutic Vaccines Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Therapeutic Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Therapeutic Vaccines Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Therapeutic Vaccines Sales Market Share by Application (2015-2020)
Table 70. Northeast Biotherapeutics Corporation Information
Table 71. Northeast Biotherapeutics Description and Major Businesses
Table 72. Northeast Biotherapeutics Therapeutic Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Northeast Biotherapeutics Product
Table 74. Northeast Biotherapeutics Recent Development
Table 75. Agenus Corporation Information
Table 76. Agenus Description and Major Businesses
Table 77. Agenus Therapeutic Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Agenus Product
Table 79. Agenus Recent Development
Table 80. Vaccinogen Inc Corporation Information
Table 81. Vaccinogen Inc Description and Major Businesses
Table 82. Vaccinogen Inc Therapeutic Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Vaccinogen Inc Product
Table 84. Vaccinogen Inc Recent Development
Table 85. CIMAB S.A Corporation Information
Table 86. CIMAB S.A Description and Major Businesses
Table 87. CIMAB S.A Therapeutic Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. CIMAB S.A Product
Table 89. CIMAB S.A Recent Development
Table 90. Dendreon Corporation Information
Table 91. Dendreon Description and Major Businesses
Table 92. Dendreon Therapeutic Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Dendreon Product
Table 94. Dendreon Recent Development
Table 95. Corixa Corporation Information
Table 96. Corixa Description and Major Businesses
Table 97. Corixa Therapeutic Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Corixa Product
Table 99. Corixa Recent Development
Table 100. AVAX Technologies Corporation Information
Table 101. AVAX Technologies Description and Major Businesses
Table 102. AVAX Technologies Therapeutic Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. AVAX Technologies Product
Table 104. AVAX Technologies Recent Development
Table 105. Global Therapeutic Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 106. Global Therapeutic Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Therapeutic Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Therapeutic Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Therapeutic Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 110. North America: Therapeutic Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Therapeutic Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 112. Europe: Therapeutic Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Therapeutic Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 114. Asia Pacific: Therapeutic Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Therapeutic Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 116. Latin America: Therapeutic Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Therapeutic Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 118. Middle East and Africa: Therapeutic Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Therapeutic Vaccines Players
Table 123. Therapeutic Vaccines Customers List
Table 124. Therapeutic Vaccines Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Therapeutic Vaccines Product Picture
Figure 2. Global Therapeutic Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Peptide Therapeutic Vaccine Product Picture
Figure 4. Cell Therapeutic Vaccine Product Picture
Figure 5. Nucleic Acid Therapeutic Vaccine Product Picture
Figure 6. Global Therapeutic Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Oncotherapy
Figure 8. Hepatitis B
Figure 9. Tuberculosis
Figure 10. Herpes Simplex Virus
Figure 11. Others
Figure 12. Therapeutic Vaccines Report Years Considered
Figure 13. Global Therapeutic Vaccines Market Size 2015-2026 (US$ Million)
Figure 14. Global Therapeutic Vaccines Sales 2015-2026 (K Units)
Figure 15. Global Therapeutic Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Therapeutic Vaccines Sales Market Share by Region (2015-2020)
Figure 17. Global Therapeutic Vaccines Sales Market Share by Region in 2019
Figure 18. Global Therapeutic Vaccines Revenue Market Share by Region (2015-2020)
Figure 19. Global Therapeutic Vaccines Revenue Market Share by Region in 2019
Figure 20. Global Therapeutic Vaccines Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Therapeutic Vaccines Revenue in 2019
Figure 22. Therapeutic Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Therapeutic Vaccines Sales Market Share by Type (2015-2020)
Figure 24. Global Therapeutic Vaccines Sales Market Share by Type in 2019
Figure 25. Global Therapeutic Vaccines Revenue Market Share by Type (2015-2020)
Figure 26. Global Therapeutic Vaccines Revenue Market Share by Type in 2019
Figure 27. Global Therapeutic Vaccines Market Share by Price Range (2015-2020)
Figure 28. Global Therapeutic Vaccines Sales Market Share by Application (2015-2020)
Figure 29. Global Therapeutic Vaccines Sales Market Share by Application in 2019
Figure 30. Global Therapeutic Vaccines Revenue Market Share by Application (2015-2020)
Figure 31. Global Therapeutic Vaccines Revenue Market Share by Application in 2019
Figure 32. North America Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 35. North America Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 36. U.S. Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Therapeutic Vaccines Market Share by Type in 2019
Figure 41. North America Therapeutic Vaccines Market Share by Application in 2019
Figure 42. Europe Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 45. Europe Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 46. Germany Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Therapeutic Vaccines Market Share by Type in 2019
Figure 57. Europe Therapeutic Vaccines Market Share by Application in 2019
Figure 58. Asia Pacific Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Therapeutic Vaccines Sales Market Share by Region in 2019
Figure 61. Asia Pacific Therapeutic Vaccines Revenue Market Share by Region in 2019
Figure 62. China Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Therapeutic Vaccines Market Share by Type in 2019
Figure 85. Asia Pacific Therapeutic Vaccines Market Share by Application in 2019
Figure 86. Latin America Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 87. Latin America Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 89. Latin America Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 90. Mexico Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 91. Mexico Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 93. Brazil Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 95. Argentina Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Therapeutic Vaccines Market Share by Type in 2019
Figure 97. Latin America Therapeutic Vaccines Market Share by Application in 2019
Figure 98. Middle East and Africa Therapeutic Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 99. Middle East and Africa Therapeutic Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Therapeutic Vaccines Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Therapeutic Vaccines Revenue Market Share by Country in 2019
Figure 102. Turkey Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 103. Turkey Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 105. Saudi Arabia Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Therapeutic Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 107. U.A.E Therapeutic Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Therapeutic Vaccines Market Share by Type in 2019
Figure 109. Middle East and Africa Therapeutic Vaccines Market Share by Application in 2019
Figure 110. North America Therapeutic Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. North America Therapeutic Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Therapeutic Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Europe Therapeutic Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Therapeutic Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Asia Pacific Therapeutic Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Therapeutic Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 117. Latin America Therapeutic Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Therapeutic Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 119. Middle East and Africa Therapeutic Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
アルコール性肝炎治療の世界市場（～2026年） Alcoholic hepatitis is a kind of liver disease usually affects people who are used to be heavy drinkers. It can cause short and long-term liver damage. Liver is a major organ of body functions to remove poisons such as alcohol from blood. It’s damaged by long time heavy drinking of alcohol. Usually …- リンパ芽球性リンパ腫治療薬の世界市場（～2026年） Lymphoblastic lymphoma (LL) is a rare type of fast-growing non-Hodgkin lymphoma (NHL). It develops when the body makes abnormal lymphocytes. It can develop from both B-cell and T-cell lymphocytes. Lymphocytes are white blood cells that fight infection. Market Analysis and Insights: Global Lymphoblas…
- ループス治療の世界市場（～2026年） Systemic lupus erythematosus (SLE) is an autoimmune disease that causes a chronic inflammatory condition. According to the report, one of the major drivers for this market is high prevalence rate. Market Analysis and Insights: Global Lupus Therapeutic Market The global Lupus Therapeutic market size …
- 濾胞性リンパ腫治療の世界市場（～2026年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…
- 色素沈着障害治療の世界市場（～2026年） Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color. Pigmentation therapies can be classified as topical drugs, microdermabrasion, chemical peels, phototherapy, and laser therapy. These therapies are availabl…